SPY315.78+1.40 0.45%
DIA259.50+2.26 0.88%
IXIC10,549.96+2.21 0.02%

Wolfe Research Initiates Coverage On Zymeworks with Outperform Rating, Announces $61 Price Target

Wolfe Research initiates coverage on Zymeworks (NYSE:ZYME) with a Outperform rating and a $61 price target.

Benzinga · -

Wolfe Research initiates coverage on Zymeworks (NYSE:ZYME) with a Outperform rating and a $61 price target.